NUTRIVANCE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
NUTRIVANCE
Largest movements
- Tangible fixed assets -€808
down €808 (-60.6%), from €1,332 to €525
- Short-term financial debts +€3,758
up €3,758 (+93.7%), from €4,011 to €7,769
- Profit (loss) carried forward -€3,491
down €3,491 (-3.3%), from -€105,385 to -€108,876
- Trade debts -€2,698
no longer reported in 2025 (was €2,698)
- Other debts +€2,045
up €2,045 (+1.9%), from €108,706 to €110,751
- Staff costs -€13,092
no longer reported in 2025 (was €13,092)
- Gross operating margin +€7,020
up €7,020 (+80.8%), from -€8,693 to -€1,673
- Other operating charges -€184
no longer reported in 2025 (was €184)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €49,826 | €49,018 | -€808 | -1.6% |
| Fixed assets | 21/28 | €1,332 | €525 | -€808 | -60.6% |
| Tangible fixed assets | 22/27 | €1,332 | €525 | -€808 | -60.6% |
| Other tangible fixed assets | 26 | €1,332 | €525 | -€808 | -60.6% |
| Current assets | 29/58 | €48,494 | €48,494 | = | 0.0% |
| Stocks and contracts in progress | 3 | €47,601 | €47,601 | = | 0.0% |
| Stocks | 30/36 | €47,601 | €47,601 | = | 0.0% |
| Amounts receivable within one year | 40/41 | €13 | €13 | = | 0.0% |
| Other amounts receivable | 41 | €13 | €13 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €879 | €879 | = | 0.0% |
| Total equity and liabilities | 10/49 | €49,826 | €49,018 | -€808 | -1.6% |
| Equity | 10/15 | -€66,011 | -€69,502 | -€3,491 | -5.3% |
| Contributions | 10/11 | €12,500 | €12,500 | = | 0.0% |
| Capital | 10 | €12,500 | €12,500 | = | 0.0% |
| Issued capital | 100 | €18,600 | €18,600 | = | 0.0% |
| Uncalled capital | 101 | €6,100 | €6,100 | = | 0.0% |
| Reserves | 13 | €26,874 | €26,874 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Legal reserve | 130 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €25,014 | €25,014 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€105,385 | -€108,876 | -€3,491 | -3.3% |
| Amounts payable | 17/49 | €115,837 | €118,520 | +€2,683 | +2.3% |
| Amounts payable within one year | 42/48 | €115,837 | €118,520 | +€2,683 | +2.3% |
| Financial debts | 43 | €4,011 | €7,769 | +€3,758 | +93.7% |
| Credit institutions | 430/8 | €4,011 | €7,769 | +€3,758 | +93.7% |
| Trade debts | 44 | €2,698 | - | -€2,698 | |
| Suppliers | 440/4 | €2,698 | - | -€2,698 | |
| Taxes, remuneration and social security | 45 | €423 | - | -€423 | |
| Taxes | 450/3 | €423 | - | -€423 | |
| Other amounts payable | 47/48 | €108,706 | €110,751 | +€2,045 | +1.9% |
| Remuneration, social security and pensions | 62 | €13,092 | - | -€13,092 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €883 | €808 | -€76 | -8.5% |
| Other operating charges | 640/8 | €184 | - | -€184 | |
| Gross operating margin | 9900 | -€8,693 | -€1,673 | +€7,020 | +80.8% |
| Operating profit (loss) | 9901 | -€22,853 | -€2,481 | +€20,371 | +89.1% |
| Financial charges | 65/66B | €954 | €1,010 | +€55 | +5.8% |
| Recurring financial charges | 65 | €954 | €1,010 | +€55 | +5.8% |
| Profit (loss) for the period before taxes | 9903 | -€23,807 | -€3,491 | +€20,316 | +85.3% |
| Profit (loss) for the period | 9904 | -€23,807 | -€3,491 | +€20,316 | +85.3% |
| Profit (loss) for the period to be appropriated | 9905 | -€23,807 | -€3,491 | +€20,316 | +85.3% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.